Acute Renal Failure after Nonmyeloablative Stem Cell Transplantation in Adults

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1, 2008, Pages 125-131

  Kersting, Sabina ^a   Dorp, Suzanne V ^a   Theobald, Matthias ^a   Verdonck, Leo F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acute graft versus host disease; Acute renal failure; Nonmyeloablative stem cell transplantation; Treatment related mortality

Indexed keywords

ANTIHYPERTENSIVE AGENT; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER GROWTH; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT INFECTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SURVIVAL; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING;

EID: 37348999641     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.09.016     Document Type: Article

References (21)

1. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101 (2003) 1620-1629
2. Gruss E., Bernis C., Tomas J.F., et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 15 (1995) 473-479
3. Hahn T., Rondeau C., Shaukat A., et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 32 (2003) 405-410
4. Hingorani S.R., Guthrie K., Batchelder A., et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 67 (2005) 272-277
5. Kersting S., Koomans H.A., Hene R.J., and Verdonck L.F. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 39 (2007) 359-365
6. Lopes J.A., Jorge S., Silva S., et al. Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 38 (2006) 707
7. Miralbell R., Sancho G., Bieri S., et al. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Int J Radiat Oncol Biol Phys 58 (2004) 809-816
8. Nash R.A., Antin J.H., Karanes C., et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96 (2000) 2062-2068
9. Parikh C.R., McSweeney P.A., Korular D., et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62 (2002) 566-573
10. Ratanatharathorn V., Nash R.A., Przepiorka D., et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92 (1998) 2303-2314
11. Zager R.A., O'Quigley J., Zager B.K., et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13 (1989) 210-216
12. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
13. Maris M., Sandmaier B.M., Maloney D.G., et al. Non-myeloablative hematopoietic stem cell transplantation. Transfus Clin Biol 8 (2001) 231-234
14. Diaconescu R., Flowers C.R., Storer B., et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 104 (2004) 1550-1558
15. Manjunath G., Sarnak M.J., and Levey A.S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 10 (2001) 785-792
16. Parikh C.R., McSweeney P., and Schrier R.W. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67 (2005) 1999-2005
17. Weiss A.S., Sandmaier B.M., Storer B., Storb R., McSweeney P.A., and Parikh C.R. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 6 (2006) 89-94
18. Thomas E.D., Storb R., Clift R.A., et al. Bone-marrow transplantation (second of two parts). N Engl J Med 292 (1975) 895-902
19. Parikh C.R., Sandmaier B.M., Storb R.F., et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 15 (2004) 1868-1876
20. Parikh C.R., Schrier R.W., Storer B., et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 45 (2005) 502-509
21. Liu H., Ding J.H., Liu B.C., Zhao G., and Chen B.A. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia. Am J Nephrol 27 (2007) 336-341